Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2008
NCT00888810
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

vildagliptin (1 trial)

Drugs in Phase 3 Trials (1)

insulin human (humulin) (2 trials)

Drugs in Phase 2 Trials (2)

lapatinib (tykerb) (1 trial)

topotecan (hycamtin) (1 trial)

Drugs in Other Trials (1)

sitagliptin (januvia) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus, Type 1 (Phase 3)

Diabetes Mellitus, Type 2 (Phase 4)

Recurrence (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 5